A new drug compound could combat tough-to-treat melanoma
Melanoma is commonly caused by the damaging effects of ultraviolet light—from sources like sunlight and tanning beds—on the DNA of skin cells. This UV damage can activate genes that encourage precancerous cells to further mutate into full-blown skin cancer. At the same time, UV damage can turn off other genes that would normally prevent tumor growth. With enough wrongly flipped switches, cancer can flourish. And melanoma is certainly flourishing. This year alone, 96,480 new instances of melanoma will be diagnosed in the United States and 7,230 Americans will die from the disease.
With so many people affected by melanoma, scientists are on the hunt for better ways to screen for melanoma risk and treat the most lethal types of skin cancer. One particularly voracious type of melanoma, caused by mutation of a gene called NRAS (which instructs cells to produce a protein of the same name, NRAS), drives 25 percent of skin cancers.
“There are immunotherapies and targeted therapies that have shown huge improvements for patients with melanoma,” said Rutao Cui, a Boston University School of Medicine professor of pharmacology and dermatology. “However, for patients with NRAS mutations, they don’t have very useful or very effective treatment strategies.”
Now, an international research team led by Cui has discovered a new way to stop the progression of melanoma by NRAS mutations with the flip of a genetic switch. Their findings were published January 31, 2019, in Cell.
Inside our bodies, proteins like NRAS play the role of dominoes, interacting with one another to switch other important gene activities on or off. The researchers set out in search of a way to interrupt the process in which mutated NRAS can instigate the growth of skin cancer. Since targeting the NRAS gene—just one of several dominoes in this type of skin cancer pathway—has proven to be so difficult, the researchers were determined to find another approach.
For NRAS to trigger cancer development, it first needs to be activated by another protein in the body. Until now, it’s been unknown exactly which protein is responsible for activating NRAS. But after testing the effect of several different proteins on the activity of NRAS, the team zeroed in on a likely culprit, a protein by the name of STK19.
STK19 is not a newly discovered protein in its own right, but its purpose has not been known until now. Cui’s team found that STK19 appears to work as an “on” switch for NRAS—activating production of NRAS proteins which, in turn, trigger the toppling of several other genetic dominoes downstream.
The researchers also found that, unlike NRAS, they could disable the STK19 gene and greatly diminish its ability to set the skin cancer sequence in motion.
Together, the team designed a new drug compound to shut down the effect of STK19 on NRAS. Then, testing its effect on skin cells cultured in petri dishes and in animal models, they proved that their compound can block NRAS activation and prevent melanoma from developing.
Cui says that this result is exciting not just for melanoma, but for other cancers as well. While the relationship between STK19 and NRAS may be particular to skin cancer, the approaches the team used to identify and block key activating proteins can be applied to find new treatments for similarly difficult-to-cure cancers.
Now the research team is looking to take their research to clinical trials to test out the STK19 inhibitor in humans, and hopefully, someday make it available as a targeted therapy to combat NRAS-driven melanomas.
In the meantime, Cui says that much work still needs to be done to not only create better and more precise treatments for patients suffering with melanoma, but also to alert vulnerable populations about the risk factors associated with the cancer.
“We need more monitoring for early diagnosis and full-body examinations for problematic spots,” says Cui, “and more proactive strategies for patients [at the highest risk of developing melanoma] to prevent cancer progression and metastasis.”
Learn more: Shutting Down Skin Cancer
The Latest on: Skin cancer
via Google News
The Latest on: Skin cancer
- Mom of mixed-race child creates ‘Brown Skin Matters’ Instagram to help doctorson September 6, 2019 at 1:15 pm
Research from 2012 published in the journal Dermatologic Clinics found that skin cancer outcomes for patients are worse for minorities. The study cited 2011 data from dermatologists, who received poor ...
- AI-based algorithm may predict nonmelanoma skin cancer in high-risk patientson September 6, 2019 at 1:13 pm
A nonmelanoma skin cancer risk prediction model using readily available information in the electronic medical records system and a deep learning approach appeared to demonstrate robust discrimination, ...
- EMA Begins Review of Skin Cancer Data for Patients Using Picatoon September 6, 2019 at 11:07 am
EMA’s Pharmacovigilance Risk Assessment Committee (PRAC) on Friday announced that it’s begun reviewing data on skin cancer in patients using Picato (ingenol mebutate), a gel for treating actinic ...
- New hair follicles can corral skin canceron September 6, 2019 at 4:58 am
The same genetic mutations that can trigger cancer in some tissues are relatively harmless in others. A new Yale study has identified an unlikely source of protection against some forms of skin ...
- New patch could detect skin cancer without a biopsyon September 5, 2019 at 9:28 pm
NEW ORLEANS — Many of us know someone who has had a mole or spot removed to check it for skin cancer. Now, there’s a new test for melanoma that looks like a BAND-AID that doesn’t require any cutting.
- U.S. Dermatology Partners to Hold Skin Cancer Screening at Swim Across America Dallas Open Water Swim to Raise Money for Cancer Researchon September 5, 2019 at 12:00 am
DALLAS, Sept. 5, 2019 /PRNewswire-PRWeb/ -- U.S. Dermatology Partners will sponsor and staff a skin cancer screening at the 9th Annual Swim Across America Dallas Open Water Swim on September 14th.
- Senior Living: Protecting your skin as you age is about more than skin canceron September 4, 2019 at 1:40 pm
Sunlight is a major cause of skin aging and skin cancer. As you age, you may start to notice more wrinkles, age spots, skin tags and thinning of your skin. Summer may be coming to an end, but that ...
- Aesthetics of skin cancer therapy may vary by treatment typeon September 4, 2019 at 6:29 am
While there are several effective options for treating non-melanoma skin cancers, some may result in better cosmetic appearance after treatment, according to researchers. In a meta-analysis of 58 ...
- Aetna misapplied preexisting condition bar to worker's skin cancer- 1st Circuiton September 3, 2019 at 5:40 pm
A U.S. appeals court on Tuesday said a Restoration Hardware Inc employee’s skin cancer was not a preexisting condition excluded from insurance coverage, because a doctor he visited before his benefits ...
- Skin cancer risk in athletes: The dangers of ultraviolet radiationon August 30, 2019 at 8:28 am
The dangers of ultraviolet radiation exposure, which most often comes from the sun, are well-known. Speaking at The Physiological Society's Extreme Environmental Physiology conference next week, W.
via Bing News